Tag: glycosylation in biosimilars

Manufacturing Challenges for Biosimilars: Why Complex Production Makes Them Harder Than Generics

Biosimilars aren't simple copies like generics-they're complex proteins made in living cells, where tiny changes in manufacturing can affect safety and effectiveness. Learn why producing them is so hard-and why it matters for patients.